683 Capital Management »

Aquestive Therapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $189k 94k 2.02
2019-12-31 $195k 33k 5.83

More positions owned by 683 Capital Management

Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
BorgWarner (BWA)
Ero Copper Corp (ERO)
Hilton Grand Vacations (HGV)
Carvana Cl A (CVNA)
Sharkninja Com Shs (SN)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Enova Intl (ENVA)
Tg Therapeutics (TGTX)
Wave Life Sciences SHS (WVE)
Ge Healthcare Technologies I Common Stock (GEHC)
Citigroup Com New (C)
Xenia Hotels & Resorts (XHR)
Ryder System (R)

View all positions for 683 Capital Management

Top funds holding Aquestive Therapeutics

Vanguard Group
Essex Investment Management
Vahanian & Associates Financial Planning
Bracebridge Capital
Janney Montgomery Scott
Marshall Wace
Connor, Clark & Lunn Investment Management
Legato Capital Management
Latash Investments
CI Private Wealth
Citadel Advisors
Two Sigma Investments
Jane Street
Millennium Management
Walleye Trading Advisors

View all funds holding Aquestive Therapeutics